Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue
05.01.2024 - Company Also Expects Fourth Quarter 2023 Revenue Above Guidance, Announces General Availability of Augmedix GoSAN FRANCISCO, Jan. 05, 2024 (GLOBE NEWSWIRE) - Augmedix, Inc. (Nasdaq: AUGX), a healthcare technology company that delivers ... Seite 1
Source: wallstreet-online.de